Securities Registration (section 12(g)) (8-a12g)
October 16 2017 - 9:39AM
Edgar (US Regulatory)
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
WASHINGTON,
DC 20549
FORM
8-A
FOR
REGISTRATION OF CERTAIN CLASSES OF SECURITIES
PURSUANT
TO SECTION 12(b) OR (g) OF
THE
SECURITIES EXCHANGE ACT OF 1934
IMMUDYNE,
INC.
(Exact
Name of Registrant as Specified in its Charter)
Delaware
|
|
76-0238453
|
(State
of Incorporation
or Organization)
|
|
(I.R.S.
Employer
Identification No.)
|
|
|
1460
Broadway
New
York, NY
|
|
10036
|
(Address
of principal executive offices)
|
|
(Zip
code)
|
Securities
to be registered pursuant to Section 12(b) of the Act:
None.
If
this form relates to the registration of a class of securities pursuant to Section 12(b) of the Exchange Act and is effective
pursuant to General Instruction A.(c) or (e), check the following box. ☐
If
this form relates to the registration of a class of securities pursuant to Section 12(g) of the Exchange Act and is effective
pursuant to General Instruction A.(d) or (e), check the following box. ☒
If
this form relates to the registration of a class of securities concurrently with a Regulation A offering, check the following
box ☐
Securities
Act registration statement or Regulation A offering statement file number to which this form relates: Not applicable.
Securities
to be registered pursuant to Section 12(g) of the Act:
Common
Stock, par value $0.01 per share
Item 1.
|
Description
of Registrant’s Securities to be Registered.
|
Immudyne,
Inc. (the “
Registrant
”) hereby incorporates by reference the description of its common stock, par value $0.01
per share, to be registered hereunder contained under the heading “Description of Capital Stock” in the Registrant’s
Registration Statement on Form S-1 (File No. 333-184487), as originally filed with the Securities and Exchange Commission
(the “
Commission
”) on October 18, 2012, as subsequently amended on December 5, 2012, January 3,
2013, January 23, 2013 and February 7, 2013 (the “
Registration Statement
”).
SIGNATURE
Pursuant
to the requirements of Section 12 of the Securities Exchange Act of 1934, the Registrant has duly caused this registration
statement to be signed on its behalf by the undersigned, thereunto duly authorized.
|
Immudyne,
Inc.
|
|
|
|
Date:
October 16, 2017
|
By:
|
/s/
Mark McLaughlin
|
|
Name:
|
Mark
McLaughlin
|
|
Title:
|
Chief
Executive Officer
|
3